Cargando…

Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study

BACKGROUND: We assessed the effect of switching patients with major depressive disorder to milnacipran following an initial selective serotonin reuptake inhibitor treatment failure, and explored potential biomarkers in their blood. METHODS: We conducted a prospective, open-label, 24-week trial. Depr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hashimoto, Tasuku, Sakurai, Daiji, Oda, Yasunori, Hasegawa, Tadashi, Kanahara, Nobuhisa, Sasaki, Tsuyoshi, Komatsu, Hideki, Takahashi, Junpei, Oiwa, Takahiro, Sekine, Yoshimoto, Watanabe, Hiroyuki, Iyo, Masaomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677766/ https://www.ncbi.nlm.nih.gov/pubmed/26677330 http://dx.doi.org/10.2147/NDT.S95067

Ejemplares similares

An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2015)

Treatment of refractory catatonic schizophrenia with low dose aripiprazole
por: Sasaki, Tsuyoshi, et al.
Publicado: (2012)

Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia
por: Oda, Yasunori, et al.
Publicado: (2015)

Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis
por: Tadokoro, Shigenori, et al.
Publicado: (2012)

Recent Discussions on Dopamine Supersensitivity Psychosis: Eight Points to Consider When Diagnosing Treatment-Resistant Schizophrenia
por: Kanahara, Nobuhisa, et al.
Publicado: (2021)

Tipepidine in adolescent patients with depression: a 4 week, open-label, preliminary study
por: Sasaki, Tsuyoshi, et al.
Publicado: (2014)

Increased Serum Levels of Oxytocin in ‘Treatment Resistant Depression in Adolescents (TRDIA)’ Group
por: Sasaki, Tsuyoshi, et al.
Publicado: (2016)

Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia
por: Oda, Yasunori, et al.
Publicado: (2015)

Tipepidine in children with attention deficit/hyperactivity disorder: a 4-week, open-label, preliminary study
por: Sasaki, Tsuyoshi, et al.
Publicado: (2014)

Autistic traits and cognitive profiles of treatment-resistant schizophrenia()
por: Nakata, Yusuke, et al.
Publicado: (2020)

Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia
por: Oishi, Kengo, et al.
Publicado: (2018)

Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report
por: Tadokoro, Shigenori, et al.
Publicado: (2017)

Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia
por: Takase, Masayuki, et al.
Publicado: (2015)

PS64. Psychiatrists' thinking about how to prescribe psychotropic drugs in out-patients with major depressive disorder and bipolar disorder in general clinical practice compared to the evidence-based guidelines.
por: Koseki, Maiko, et al.
Publicado: (2016)

Onset Pattern and Long-Term Prognosis in Schizophrenia: 10-Year Longitudinal Follow-Up Study
por: Kanahara, Nobuhisa, et al.
Publicado: (2013)

Successful rechallenge with paliperidone after clozapine treatment for a patient with dopamine supersensitivity psychosis
por: Kobayashi, Remiko, et al.
Publicado: (2020)

Fluvoxamine may prevent onset of psychosis: a case report of a patient at ultra-high risk of psychotic disorder
por: Tadokoro, Shigenori, et al.
Publicado: (2011)

First-episode psychosis in treatment-resistant schizophrenia: a cross-sectional study of a long-term follow-up cohort
por: Kanahara, Nobuhisa, et al.
Publicado: (2018)

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2010)

Cyclothymic Temperament is Associated with Poor Medication Adherence and Disordered Eating in Type 2 Diabetes Patients: A Case–Control Study
por: Yamamoto, Tetsuya, et al.
Publicado: (2021)

Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2012)

Correction: Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2013)

Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial
por: Hashimoto, Tasuku, et al.
Publicado: (2016)

Efficacy of Asenapine in Drug-resistant Psychotic Patients with Dopamine Supersensitivity Psychosis: Two Cases
por: Kanahara, Nobuhisa, et al.
Publicado: (2023)

Effects of etizolam and ethyl loflazepate on the P300 event-related potential in healthy subjects
por: Fukami, Goro, et al.
Publicado: (2010)

Improvement of the noradrenergic symptom cluster following treatment with milnacipran
por: Kasper, Siegfried, et al.
Publicado: (2011)

Treatment of patients with comorbid depression and diabetes with metformin and milnacipran
por: Hofmann, Peter
Publicado: (2010)

Treatment of puberty trichotillomania with low-dose aripiprazole
por: Sasaki, Tsuyoshi, et al.
Publicado: (2015)

Treatment of phantom bite syndrome with milnacipran – a case series
por: Toyofuku, Akira, et al.
Publicado: (2006)

Milnacipran: recent findings in depression
por: Montgomery, Stuart, et al.
Publicado: (2010)

Antidepressant therapy with milnacipran and venlafaxine
por: Mansuy, Lucilla
Publicado: (2010)

Milnacipran: a unique antidepressant?
por: Kasper, Siegfried, et al.
Publicado: (2010)

Milnacipran for the management of fibromyalgia syndrome
por: Ormseth, Michelle J, et al.
Publicado: (2010)

Possible effect of blonanserin on gambling disorder: A clinical study protocol and a case report
por: Shiina, Akihiro, et al.
Publicado: (2021)

Psychological Distress Symptoms Associated With Life Events in Patients With Bipolar Disorder: A Cross-Sectional Study
por: Sato, Aiko, et al.
Publicado: (2018)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
por: Kamijima, Kunitoshi, et al.
Publicado: (2013)

Effect of high-dose milnacipran in patients with depression
por: Hayashi, Masatoshi, et al.
Publicado: (2007)

Role and rationale for the use of milnacipran in the management of fibromyalgia
por: Kranzler, Jay D, et al.
Publicado: (2010)

Evaluation of the Neurological Safety of Epidural Milnacipran in Rats
por: Lim, Seung Mo, et al.
Publicado: (2012)

Effect of milnacipran on body weight in patients with fibromyalgia
por: Arnold, Lesley M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ffu3b9fmd0catebre0qfid8rfn